ACTRN12605000231640
Terminated
Phase 3
A clinical trial of dexmedetomidine or remifentanil sedation for awake fibreoptic intubation
Dr Sarah Harper0 sites20 target enrollmentAugust 26, 2005
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Dr Sarah Harper
- Enrollment
- 20
- Status
- Terminated
- Last Updated
- 6 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Awake fibreoptic intubation, no contraindication to remifentanil or dexmedetomidine.
Exclusion Criteria
- •Chronic alpha\-2 agonist or opioid therapy, allergy or previous adverse reaction to study drugs, uncontrolled hypertension, heart \<50, 2nd or 3rd degree heart block, severe ventricular, renal, hepatic or respiratory dysfuction, pregnancy or lactation.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 2
The Effect of Dexmedetomidine on renal colicRenal colic.Unspecified renal colicIRCT2015120625402N1Ahvaz Jundishapur University of Medical Sciences160
Recruiting
Phase 4
A randomised controlled trial of dexmedetomidine compared to placebo to reduce pain after spinal fusion surgeryPainSpinal fusion surgeryAnaesthesiology - AnaestheticsNeurological - Other neurological disordersACTRN12621000557831The Royal Melbourne Hospital128
Recruiting
Not Applicable
A Study To Compare Efficacy Of Dexmedetomidine And Midazolam For Sedation And Reduction Of Dose Of Propofol In Minor Gynaecological Day Care SurgeriesCTRI/2018/04/013106A
Completed
Phase 2
Study about efficacy of Dexmedetomidine as a novel sedative agent during ESD for esophageal cancerJPRN-UMIN000017302Department of Gastroenterology,Cancer Institute Hospital65
Not yet recruiting
Phase 4
Comparative Study of Dexmedetomidine, Dexamethasone, and Clonidine Drugs With Ropivacaine in Upper Limb Surgery Under Supraclavicular Brachial Plexus Block.CTRI/2024/01/062007MESH PRASAD YADAV